Quinidine therapy and therapeutic drug monitoring in four patients with KCNT1 mutations.
Yoshitomi S, Takahashi Y, Yamaguchi T, Oboshi T, Horino A, Ikeda H, Imai K, Okanishi T, Nakashima M, Saitsu H, Matsumoto N, Yoshimoto J, Fujita T, Ishii A, Hirose S, Inoue Y.
Yoshitomi S, et al. Among authors: fujita t.
Epileptic Disord. 2019 Feb 1;21(1):48-54. doi: 10.1684/epd.2019.1026.
Epileptic Disord. 2019.
PMID: 30782581